Seizure-treating device allows for targeted brain delivery; Phosphagenics expands to animal market;

> Scientists are working on a closed-loop implantable device to treat seizures, detecting brain patterns and delivering drugs as needed without external controls. Report

> Australian drug delivery firm Phosphagenics is expanding into the animal market, partnering with Equine Nutrition Australia to develop compounds for racehorses. News

> Researchers have discovered that porous nanosilica provide an ideal platform for delivering anti-inflammatory treatments to the throat, tonsils and sinuses. More

> Scientists at the University of Texas at San Antonio have received $200,000 in seed funding to expand their light-activated nanoparticle technology. Item

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.